Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (8,499,974)	$ (5,172,992)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	407,146	417,188
Amortization	19,334	32,023
Amortization of right-of-use assets	249,972	284,519
Share-based compensation expense	158,288	163,924
Loan and accrued interest forgiveness on note payable	0	(821,515)
Inventory reserve	3,800	0
Loss on disposal of fixed asset	0	2,850
Changes in operating assets and liabilities:
Accounts receivable	(98,872)	(17,669)
Inventory	(138,666)	(18,958)
Other assets	359,307	498,878
Accounts payable	(49,449)	(237,443)
Accrued expenses	45,828	(510,730)
Lease liabilities	(290,104)	(312,893)
Other liabilities	(30,696)	9,935
Net cash used in operating activities	(7,864,086)	(5,682,883)
Cash flows from investing activities:
Purchases of property and equipment	(313,598)	(188,245)
Net cash used in investing activities	(313,598)	(188,245)
Cash flows from financing activities:
Proceeds from issuance of common stock	16,151	31,725,645
Payments of deferred offering costs	(232,845)	(1,578,643)
Repayment of note payable	(365,926)	(302,343)
Payments under lease obligations	(17,075)	(15,448)
Net cash (used in) provided by in financing activities	(599,695)	29,829,211
Net change in cash and cash equivalents	(8,777,379)	23,958,083
Cash and cash equivalents:
Beginning of period	24,783,029	3,322,226
End of period	16,005,650	27,280,309
Cash paid for:
Interest	9,622	11,155
Income taxes	5,050	800
Non-cash investing and financing activities:
Property and equipment costs included in accounts payable	23,037	0
Prepaid insurance financed with promissory notes	280,577	320,866
Conversion of convertible preferred stock to common stock	$ 0	$ 55,360,897